Find the latest news from Adjuvance Technologies

Adjuvance Technologies Presents Clinical Data at IDWeek 2021

Lincoln, NE – October 4, 2021 – Adjuvance Technologies Inc., a privately-held, clinical-stage biopharmaceutical company developing next generation saponin adjuvants and vaccines for infectious disease and immuno-oncology announced that data from the first-in-human...

read more

Adjuvance Technologies to Present at 2021 Bio Digital

Lincoln, NE – June 11, 2021 – Adjuvance Technologies Inc. announced today that it has been selected to deliver a company presentation at 2021 BIO Digital, the premier biotech event. BIO Digital is scheduled June 10-11 & 14-18, 2021. J. Tyler Martin MD, CEO and...

read more